Skip to content
  • Home
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Latest News
  • Business
  • Finance
  • Contact Us

Search

  • Home
  • SeaPRwire
  • ACN
  • JCN
  • EQS
  • Contact
亚洲新闻、事件、深度報道

trial

JCN Newswire
Read More

Fuel Cell Bus Trials on the BRT Hikoboshi Line

ruth 8 February
3 minutes

TOKYO, Feb 8, 2023 – (JCN Newswire via SEAPRWire.com) – Fukuoka Prefecture, Commercial Japan Partnership Technologies Corporation (CJPT), and Kyushu Railway Company (JR Kyushu) have entered an agreement to conduct […]

JCN Newswire
Read More

DOCOMO Conducts World’s First Trial of Transmissive Metasurface on Window to Deliver Indoor Radio Waves to Outdoor Foot of Building

ruth 30 January
4 minutes

TOKYO, Jan 30, 2023 – (JCN Newswire via SEAPRWire.com) – NTT DOCOMO, INC. announced today that it has succeeded in what it believes to be the world’s first trial of […]

ACN Newswire
Read More

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

indie 2 September
3 minutes

SYDNEY, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled “Evolution […]

ACN Newswire
Read More

Zhaoke Ophthalmology Announces 2022 Interim Results

indie 24 August
15 minutes

HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”, SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research […]

ACN Newswire
Read More

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

indie 15 August
3 minutes

HONG KONG, Aug 15, 2022 – (ACN Newswire via SEAPRWire.com) – On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, […]

ACN Newswire
Read More

Virios Therapeutics: The ‘Virus Hypothesis’ That Stands to Change the Lives of 10M Americans

indie 9 August
7 minutes

NEW YORK, NY, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – PCG Digital — Life may change for the better for the 10 million Americans suffering from fibromyalgia. The […]

ACN Newswire
Read More

Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery

indie 29 June
3 minutes

LAUSANNE, Switzerland, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough […]

ACN Newswire
Read More

Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022

indie 29 June
2 minutes

SEOUL, S.KOREA, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was today […]

ACN Newswire
Read More

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.

indie 15 June
4 minutes

HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-based […]

ACN Newswire
Read More

Novotech’s APAC and USA Leadership Teams at BIO 2022

indie 15 June
3 minutes

SAN DIEGO, CA, Jun 14, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will […]

JCN Newswire
Read More

Eisai Initiates Preparation for New Drug Application, Based on the Results of an Investigator-Initiated Clinical Trial of Ultrahigh-Dose Mecobalamin for Amyotrophic Lateral Sclerosis in Japan

ruth 10 May
4 minutes

TOKYO, May 10, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. today announced that it has initiated preparation on a New Drug Application for ultrahigh-dose mecobalamin (development code: […]

ACN Newswire
Read More

Essex Bio-Technology Announces 2021 Financial Results

indie 22 March
10 minutes

HONG KONG, Mar 22, 2022 – (ACN Newswire via SEAPRWire.com) – Essex Bio-Technology Ltd (“Essex” or the “Group”, Stock Code: 1061.HK) today announced the annual results for the year ended […]

JCN Newswire
Read More

Fujitsu Leverages World’s Fastest Supercomputer and AI Tech in Joint Field Trial for Safe and Efficient Tsunami Evacuations in Kawasaki City

ruth 3 March
6 minutes

TOKYO, Mar 3, 2022 – (JCN Newswire via SEAPRWire.com) – The International Research Institute of Disaster Science (IRIDeS) at Tohoku University, the Earthquake Research Institute at the University of Tokyo, […]

ACN Newswire
Read More

Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report

indie 9 February
3 minutes

SYDNEY, Feb 9, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO, has been recognized as a top 10 CRO in the 2021 CenterWatch […]

SeaPRwire

Only Goldman banker to stand trial for 1MDB to get his day in court today

elean 7 February
0 min

ACN Newswire
Read More

B-cell lymphoma clinical trials now open on the TrialWire Platform

indie 5 January
3 minutes

ADELAIDE, AUS, Jan 5, 2022 – (ACN Newswire via SEAPRWire.com) – TrialWire(TM) is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform. More than […]

ACN Newswire
Read More

Autism clinical trials now open on the TrialWire Platform

indie 5 January
3 minutes

ADELAIDE, AUS, Jan 5, 2022 – (ACN Newswire via SEAPRWire.com) – TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform. More than […]

ACN Newswire
Read More

SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03

indie 30 November
3 minutes

HONG KONG, Nov 30, 2021 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab”, or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, […]

JCN Newswire
Read More

Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050, a Novel Individualized Neoantigen Cancer Vaccine

ruth 23 November
13 minutes

Strasbourg, France & Tokyo, Japan, Nov 23, 2021 – (JCN Newswire via SEAPRWire.com) – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment […]

ACN Newswire
Read More

Apollomics Inc. Doses First Patient in Phase 3 Clinical Trial with APL-106 (Uproleselan Injection) in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia

indie 22 November
4 minutes

Foster City, CA, Shanghai and Hangzhou, China, Nov 22, 2021 – (ACN Newswire via SEAPRWire.com) – Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- […]

Previous1 2 3 Next

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    

网站导航

  • Home
  • Latest News
  • Business
  • Finance
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact Us

Search

  • Home
  • Latest News
  • Business
  • Finance
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • EQS Newswire
  • Contact Us
Copyright © 2020 ASEANPR.Com All rights reserved.